Clinical trials
Phase 3 Pericarditis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azienda Sanitaria Locale 3, Torino | 3 |
| Cardiol Therapeutics Inc. | 1 |
| Istituto Giannina Gaslini | 1 |
| Kiniksa Pharmaceuticals (UK), Ltd. | 1 |
| Ottawa Heart Institute Research Corporation | 1 |
| R-Pharm International, LLC | 1 |
| Valentina Puentmann | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pericarditis | 9 |
| Recurrence | 3 |
| Microvascular Angina | 1 |
| Myocarditis | 1 |
| Post-Acute COVID-19 Syndrome | 1 |
| Postpericardiotomy Syndrome | 1 |
| Vascular Remodeling | 1 |
| Ventricular Dysfunction, Left | 1 |
| Ventricular Remodeling | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.